Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leading Edge Clinic is a specialized telehealth practice that provides clinical care for patients suffering from Long COVID, Post-Vaccine Syndrome, and related chronic conditions. Co-founded by Dr. Pierre Kory and Scott Marsland, the clinic is recognized for its implementation of the Front Line COVID-19 Critical Care Alliance (FLCCC) treatment protocols. The practice utilizes a combination of repurposed medications, such as ivermectin and low-dose naltrexone, and integrative therapies to address systemic inflammation and immune dysregulation. By offering personalized consultations and remote monitoring, the clinic serves a global patient base seeking alternative and specialized medical interventions for complex syndromes. Their approach emphasizes patient-centered care and the management of multi-system inflammatory responses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leading Edge Clinic.